NA
ID: ALA4514487
PubChem CID: 155539361
Max Phase: Preclinical
Molecular Formula: C37H35NO8S
Molecular Weight: 653.75
Molecule Type: Unknown
Associated Items:
This compound is not in our inventory system
ID: ALA4514487
PubChem CID: 155539361
Max Phase: Preclinical
Molecular Formula: C37H35NO8S
Molecular Weight: 653.75
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@]12C[C@@]34C=C(Sc5cccc(-c6ccc(C=O)cc6)c5)C(=O)[C@@](C)(CCC(=O)Nc5c(O)ccc(C(=O)O)c5O)[C@@H]3[C@H](C[C@@H]1C4)O2
Standard InChI: InChI=1S/C37H35NO8S/c1-35(13-12-29(41)38-30-26(40)11-10-25(31(30)42)34(44)45)32-27-15-23-16-37(32,19-36(23,2)46-27)17-28(33(35)43)47-24-5-3-4-22(14-24)21-8-6-20(18-39)7-9-21/h3-11,14,17-18,23,27,32,40,42H,12-13,15-16,19H2,1-2H3,(H,38,41)(H,44,45)/t23-,27+,32+,35+,36+,37-/m1/s1
Standard InChI Key: PNLDACVPVKOFDL-BRLAMNFDSA-N
Molfile:
RDKit 2D 49 55 0 0 0 0 0 0 0 0999 V2000 35.0053 -14.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 29.1110 -13.3638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 33.7659 -14.7980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 30.5701 -13.3638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 29.8446 -13.7824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 34.1970 -13.5918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 34.1970 -14.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 32.9659 -15.0384 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 33.3846 -14.3254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 33.7535 -14.0104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 35.6520 -14.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 34.5369 -15.1877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 28.3856 -13.7824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 31.2913 -13.7824 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 34.9307 -13.3597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 34.7566 -13.7700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 35.6520 -13.7700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 33.2561 -13.6871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 29.1110 -12.5265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 33.4758 -13.3638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 32.0167 -13.3638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 30.5701 -12.5265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 28.3856 -14.6197 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 29.8323 -12.1078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 34.9307 -12.5224 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 32.0167 -12.5265 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 32.7503 -13.7824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 29.8446 -14.6197 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 27.6602 -13.3638 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 33.9773 -15.6104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 31.2913 -12.0954 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 34.1970 -12.8291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 33.7535 -13.1690 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 34.8602 -15.1213 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 36.3614 -13.3574 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 37.0735 -13.7655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 37.0735 -14.5836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 37.7847 -14.9915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 38.4952 -14.5789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 38.4900 -13.7540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 37.7782 -13.3496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 39.1927 -13.3398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 39.9065 -13.7470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 40.6140 -13.3327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 40.6090 -12.5111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 39.8905 -12.1057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 39.1859 -12.5225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 41.3165 -12.0950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 41.3099 -11.2743 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 5 1 0 3 12 1 0 4 14 1 0 5 4 2 0 6 7 1 0 7 1 1 0 3 8 1 6 9 7 1 0 10 16 1 0 11 1 1 0 12 1 1 0 13 2 1 0 14 21 1 0 15 17 1 0 1 16 1 1 17 11 2 0 18 10 1 0 19 24 1 0 20 6 1 0 21 27 1 0 22 4 1 0 23 13 2 0 24 22 2 0 25 15 2 0 26 21 2 0 27 20 1 0 28 5 1 0 29 13 1 0 30 3 1 0 31 22 1 0 6 32 1 1 10 33 1 1 7 34 1 6 10 3 1 0 8 9 1 0 9 18 1 1 15 6 1 0 2 19 2 0 17 35 1 0 35 36 1 0 36 37 2 0 37 38 1 0 38 39 2 0 39 40 1 0 40 41 2 0 41 36 1 0 42 43 2 0 43 44 1 0 44 45 2 0 45 46 1 0 46 47 2 0 47 42 1 0 40 42 1 0 45 48 1 0 48 49 2 0 M END
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 653.75 | Molecular Weight (Monoisotopic): 653.2083 | AlogP: 6.83 | #Rotatable Bonds: 9 |
Polar Surface Area: 150.23 | Molecular Species: ACID | HBA: 8 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 2.96 | CX Basic pKa: ┄ | CX LogP: 6.36 | CX LogD: 2.87 |
Aromatic Rings: 3 | Heavy Atoms: 47 | QED Weighted: 0.14 | Np Likeness Score: 1.32 |
1. Deng Y, Weng X, Li Y, Su M, Wen Z, Ji X, Ren N, Shen B, Duan Y, Huang Y.. (2019) Late-Stage Functionalization of Platensimycin Leading to Multiple Analogues with Improved Antibacterial Activity in Vitro and in Vivo., 62 (14): [PMID:31265289] [10.1021/acs.jmedchem.9b00616] |
Source(1):